Thomas Crighton

Thomas Crighton

Auto-generated profile, based on publicly available information

Thomas Crighton

Department of Molecular and Clinical Cancer Medicine, University of Liverpool North West Cancer Research Centre, University of Liverpool, 200 London Road, Liverpool L69 7ZB, UK

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Cell Reports
Verified
Journal Article
Open access
IPIoannis Poursaitidis
Ioannis Poursaitidis
XWXiaomeng Wang
Xiaomeng Wang
TCThomas Crighton
Thomas Crighton
CLChristiaan Labuschagne
Christiaan Labuschagne
DMDavid Mason
David Mason
RLRichard F. Lamb
Richard F. Lamb
Cancer cells reprogram their metabolism, altering both uptake and utilization of extracellular nutrients. We individually depleted amino acid nutrients from isogenic cells expressing commonly activated oncogenes to identify correspondences between nutrient supply and viability. In HME (human mammary epithelial) cells, deprivation of cystine led to increased cell death in cells expressing an activated epidermal growth factor receptor (EGFR) mutant. Cell death occurred via synchronous ferroptosis, with generation of reactive oxygen species (ROS). Hydrogen peroxide promoted cell death, as both catalase and inhibition of NADPH oxidase 4 (NOX4) blocked ferroptosis. Blockade of EGFR or mitogen-activated protein kinase (MAPK) signaling similarly protected cells from ferroptosis, whereas treatment of xenografts derived from EGFR mutant non-small-cell lung cancer (NSCLC) with a cystine-depleting enzyme inhibited tumor growth in mice. Collectively, our results identify a potentially exploitable sensitization of some EGFR/MAPK-driven tumors to ferroptosis following cystine depletion.